medical industry information

Drugdu.com (Ddu), the leading global pharmaceutical and medical device B2B online platform, attended the CMEF exhibition in Shanghai and showcased their new “Internet + cross-border medical trade” marketing model. At the same time, a symposium for the Ddu Trade Accelerator was held to share insight on new methods of taking advantage of online promotions to open up international markets and accelerate cross-border trade. The conference was very successful, locking the attention of people present and opening up opportunities for the sharing of ideas and re-thinking of marketing strategies. According to statistics, the global medical device market was estimated to be worth 406.3 billion USD in 2016, and is expected to exceed 477.5 billion USD by 2020. With the domestic market gradually becoming more saturated, more and more  medical device suppliers  are paving their way to explore international markets. However, the promotion of medical devices is beset with difficulties and the

Operation rooms need to be equipped with advanced instruments if we see the number range of surgical procedures handled on a daily basis across the world. This ensures better handling by surgeons and other staff, more flexibility, greater operational efficiency, and better results. Creation of hybrid operating rooms is the new swing in the operating room equipment market, wherein surgical and non-surgical functions are being carried out. The operating room equipment market is categorized into Europe, North America, Asia Pacific, etc. Operating room equipment has a thriving market in North America and Europe. These countries also offer great potential for revenue generation. These regions also assume importance in view of the fact that there is a strong demand for constant upgrading of operating room equipment. In 2017, the movable imaging systems segment generated revenue of US$8,384.9 million and held a solid position in the operating room equipment segment. Biomedical syst

Though the US stands first in the race in terms of sales and growth, it is highly believed that China would reach the peak in the pharma market by 2022. At present, since there has been a decrease in public health funding, there has been a slight fall in pharmerging countries like Brazil, Russia, India and China (BRIC). But it is believed that the condition of these pharmerging countries will improve in the next five years [1]. Spending on medicines in pharmerging countries in 2022 (in billion US dollars) [2] Market Scope predicted that China’s ophthalmic market would reach $4.0 billion from $2.7 billion in 2022 [3].  Though the economy of China was initially quite slow, the country has increased access to medical care with more government spending on health and a rising supplemental health insurance markets. For the last two years, China has implemented many reforms to improve the quality of healthcare by regulating  medical device products  and pharmaceuticals, speeding up t

Health-Check-Up Through Sweat Monitoring Wearable Device  171 Wearable Medical Device  Cincinnati-based startup Eccrine System has developed a health  wearable   medical device products called Sweatronics which tracks your health using sweat. Other bodily fluids like urine and blood contain plenty of the body information’s but are not as easy to collect. However, Sweatronics needs only sweat samples that is produces automatically while working or even sleeping. The device is to be worn around the wrist, which consists of a sweat collection unit, sensor, and electronics that make contact with skin and uses electrochemical aptamer technology which helps DNA binding to select biomarkers to scale the target of choice, the data can be sent via wireless connection to a smartphone. This device was first introduced to the US air force as a project program. A recent study showed that individuals could be differentiated from one another due to the unique metabolites in their

It is a herculean task among the scientists to find a single  cure for cancer . A research team from the University of East Anglia developed a new technique for cancer treatment. Cancer therapy that could cut off the blood supply to a tumor could be more effective along with the chemotherapeutic drugs. The research study revealed that tumor growth could be reduced by targeting the expression of Beta3-integrin along with microtubule-targeting agents (MTAs) chemotherapy. Beta3-integrin was the better anti-angiogenic target since it was expressed in tumor blood vessels, unlike normal cells. Lead researcher Stephen Robinson said,  “Tumours must recruit their own blood supply to grow beyond a very small size and this process is called angiogenesis ; A nti-angiogenic drugs stop tumors from growing their own blood vessels, and this, in turn, can slow the growth of cancer, or shrink it. Targeting angiogenesis is therefore seen as crucial in many anti-cancer strategies; however many anti-angiog

Determined to cap the profits of private hospitals in Delhi and the NCR region, Delhi health minister Satyendra Jain has announced an array of new rules. He clearly stated that hospitals will be mandated to sell essential medicines at MRP and can no longer charge a markup. It was found earlier by the National Pharmaceuticals Pricing Authority (NPPA), India’s  pharmaceutical drugs  pricing watchdog, that consumers are forced by private hospitals to buy from their in-house pharmacies where hospitals would then make exorbitant profits of around 1,700 % on drugs, diagnostics, and consumables. Prices for non-essential medicines have been capped at 50% above MRP. An analysis by the NPPA pointed to the fact that manufacturers and hospitals were being arm-wrestled into paying exorbitant prices. The findings further revealed that non-scheduled drugs and diagnostic services formed the major bulk of bills charged to patients. Instead of prescribing scheduled medicines, doctors and hosp

India-based Omega Healthcare has categorically stated that the growth of data analytics and  cloud intelligence   firms in the Indian healthcare sector has little scope. The company plans to hire around 1,200 - 1,500 people for exploring emerging markets like the United Arab Emirates. Indian healthcare providers have not picked up the pace in the empowering technology sectors at a time when retail, manufacturing, and banking industries have adapted to cloud-based systems and used data analytics for improving processes. Omega Healthcare has stated that the absence of a government mandate on health insurance is a major growth impediment for the sector even as the company has extended its data and revenue management services to Health Insurance Company, hospitals, and healthcare providers. A statement issued by the company points to the fact that though there has been a substantial improvement in healthcare delivery services in the country, there is a lack of effort in the tracking and co

Drugdu.com   (Ddu), the leading global pharmaceutical and medical device B2B online platform, attended the CMEF exhibition in Shanghai and showcased their new “Internet + cross-border medical trade” marketing model. At the same time, a symposium for the Ddu Trade Accelerator was held to share insight on new methods of taking advantage of online promotions to open up international markets and accelerate cross-border trade. The conference was very successful, locking the attention of people present and opening up opportunities for the sharing of ideas and re-thinking of marketing strategies. According to statistics, the global medical device market was estimated to be worth 406.3 billion USD in 2016 and is expected to exceed 477.5 billion USD by 2020. With the domestic market gradually becoming more saturated, more and more   medical device suppliers   are paving their way to explore international markets. However, the promotion of medical devices is beset with difficulties and the

Telehealth is emerging as an effective recovery tool for stroke patients undergoing physical rehabilitation at a clinic and recovering at home. Results from a study conducted by Dr. Steven C. Cramer at the University of California at Irvine have concluded that increased telemedicine usage at home by patients has resulted in increased mobility as also for those traveling to receive in-person rehab. The findings were presented at the 2018 European Stroke Organization Conference in Gothenburg, Sweden. The findings noted that patient outcomes are improved in a supervised rehabilitation program through occupational and physical therapy with motor deficits being a major contributor to post-stroke disability. Determining the effectiveness of a comprehensive in-home telehealth therapy program in comparison to in-clinic rehabilitation remains pertinent in the face of several patients receiving suboptimal therapy for reasons including cost, availability and travel difficulties. The s

With 1,00,000 laboratories and a vast number of hospitals constituting a bulk of the Indian IVD industry, India broadly accounts for one percent of the global diagnostic industry, hardly a fact to be proud of. By 2022, the Indian IVD industry is anticipated to show an exponential growth of 20 percent and clock figures of USD 32 billion by augmenting infrastructural strengths and rolling out key policy initiatives to fast-pace production efforts and derive quick results. The Indian medical diagnostics industry chiefly comprises of In-vitro diagnostics (IVD) and in-vivo diagnostics which are witnessing tremendous growth and changing the paradigms of the business. The growth in key market segments like biochemistry, immunoassays, hematology, reagents, molecular diagnostics, and microbiology or tissue diagnostics is likely to position the Indian medical diagnostics market in the 15-20 percent growth rate range in the near term and earn revenues of around USD 1.7 billion The IVD sector

Discovery of Muscle Builder Pill | Drugdu.com May 30, 2018 An ultimate focus on a specific protein named myostatin has led to the discovery of a muscle building pill, that could easily reduce gym visits. Suppression of myostatin production could increase healthier muscle mass, which would act as markers in improving kidney and heart health. The research work was conducted at Augusta University in the US state of Georgia. The lead researcher Dr. Joshua Butcher said, “Ultimately, the goal of our research would be to create a pill that mimics the effect of exercise and protects against obesity; a pill that inhibits myostatin could also have applications for muscle-wasting diseases, such as cancer, muscular dystrophy, and AIDS.” Studies suggested that obese patients secrete high levels of myostatin which results in exercise becoming more strenuous and difficulty in building up muscle. “Given that exercise is one of the most effective interventions for